Alterations in Skeletal Muscle Indicators of Mitochondrial Structure and Biogenesis in Patients with Type 2 Diabetes and Heart Failure: Effects of Epicatechin Rich Cocoa

Clinical and Translational Science

Volumn 5, Issue 1, 2012, Pages 43-47

  Taub, Pam R ^a,b   Ramirez Sanchez, Israel ^a,c   Ciaraldi, Theodore P ^a,b   Perkins, Guy ^a   Murphy, Anne N ^a   Naviaux, Robert ^a   Hogan, Michael ^a   Maisel, Alan S ^a,b   Henry, Robert R ^a,b   Ceballos, Guillermo ^c   Villarreal, Francisco ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

Epicatechin; Heart failure; Mitochondrial biogenesis; Skeletal muscle; Type 2 diabetes

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CYCLIC GMP; EPICATECHIN; HIGH DENSITY LIPOPROTEIN; MITOCHONDRIAL TRANSCRIPTION FACTOR A; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PORIN;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; BIOGENESIS; CACAO; DISEASE CLASSIFICATION; ELECTRON MICROSCOPY; HEART FAILURE; HUMAN; MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; SKELETAL MUSCLE;

AGED; BEVERAGES; BIOLOGICAL MARKERS; BIOPSY; CACAO; CALIFORNIA; CANDY; CATECHIN; DIABETES MELLITUS, TYPE 2; FUNCTIONAL FOOD; HEART FAILURE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPIDS; MIDDLE AGED; MITOCHONDRIA, MUSCLE; MITOCHONDRIAL PROTEINS; NATRIURETIC PEPTIDE, BRAIN; QUADRICEPS MUSCLE; TIME FACTORS; TREATMENT OUTCOME;

MUS; THEOBROMA CACAO;

EID: 84857649267     PISSN: 17528054     EISSN: 17528062     Source Type: Journal    
DOI: 10.1111/j.1752-8062.2011.00357.x     Document Type: Article

References (13)

1. Drexler H, Riede U, Munzel T, Konig H, Funke E, Just H. Alterations of skeletal muscle in chronic heart failure. Circulation. 1992; 85(5): 1751-1759.
2. Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, Miyazaki Y, Konahe I, Costello M, Saccone R, et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci USA. 2003; 100(14): 8466-8471.
3. Nisoli E, Clementi E, Carruba MO, Moncada S. Defective mitochondrial biogenesis: a hallmark of the high cardiovascular risk in the metabolic syndrome? Circ Res. 2007; 100(6): 795-806.
4. Nogueira L, Ramirez-Sanchez I, Perkins G, Murphy A, Taub P, Ceballos G, Villarreal F, Hogan M, Malek M. (-)-Epicatechin enhances fatigues resistance and oxidative capacity in mouse muscle. Journal of Physiology. 2011; 589(18): 4615-4631.
5. Corti R, Flammer AJ, Hollenberg NK, Luscher TF. Cocoa and cardiovascular health. Circulation. 2009; 119(10): 1433-1441.
6. Mostofsky E, Levitan EB, Wolk A, Mittleman MA. Chocolate intake and incidence of heart failure: a population-based prospective study of middle-aged and elderly women. Circ Heart Fail 2010; 3(5): 612-616.
7. Keteyian SJ, Fleg JL, Brawner CA, Pina IL. Role and benefits of exercise in the management of patients with heart failure. Heart Fail Rev. 2010; 15(6): 523-530.
8. Regensteiner JG, Sippel J, McFarling ET, Wolfel EE, Hiatt WR. Effects of non-insulin-dependent diabetes on oxygen consumption during treadmill exercise. Med Sci Sports Exerc. 1995; 27(5): 661-667.
9. Nielsen J, Mogensen M, Vind BF, Sahlin K, Hojlund K, Schroder HD, Ortenblad N. Increased subsarcolemmal lipids in type 2 diabetes: effect of training on localization of lipids, mitochondria, and glycogen in sedentary human skeletal muscle. Am J Physiol Endocrinol Metab. 2010; 298(3): E706-E713.
10. Chomentowski P, Coen PM, Radikova Z, Goodpaster BH, Toledo FG. Skeletal muscle mitochondria in insulin resistance: differences in intermyofibrillar versus subsarcolemmal sub-populations and relationship to metabolic flexibility. J Clin Endocrinol Metab. 2011; 96(2): 494-503.
11. Toledo FG, Menshikova EV, Ritov VB, Azuma K, Radikova Z, DeLany J, Kelley DE. Effects of physical activity and weight loss on skeletal muscle mitochondria and relationship with glucose control in type 2 diabetes. Diabetes. 2007; 56(8): 2142-2147.
12. Pagel-Langenickel I, Schwartz DR, Arena RA, Minerbi DC, Johnson DT, Waclawiw MA, Cannon RO 3rd, Balaban RS, Tripodi DJ, Sack MN. A discordance in rosiglitazone mediated insulin sensitization and skeletal muscle mitochondrial content/activity in Type 2 diabetes mellitus. Am J Physiol Heart Circ Physiol. 2007; 293(5): H2659-H2666.
13. Mensink M, Hesselink MK, Russell AP, Schaart G, Sels JP, Schrauwen P. Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1 alpha and PPAR beta/delta gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus. Int J Obes (Lond). 2007; 31 (8): 1302-1310.